Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MANHYPIC trial: mannitol versus hypertonic saline for severe intracranial hypertension after severe traumatic brain injury
2008-005134-75Phase 3Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2008
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intracranial hypertension (IH) comparing 20% mannitol with 3.9% hypertonic sodium chloride (2 arms). Primary endpoint: Definitive failure rate. Started Oct 2008; status: active.
02
Drugs
Bronchitolsodium chloride
03
Conditions
intracranial hypertension (IH)
Beyond the preview
Go deeper on 2008-005134-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005134-75.